Evidence map›Paper›PMID 29707113›Full record

ArticleOncotarget2018

Javier A García-Vilas, Ian Morilla, Anibal Bueno, Beatriz Martínez-Poveda, Miguel Ángel Medina, Juan A G Ranea

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Javier A García-VilasUniversidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, And IBIMA (Biomedical Research Institute of Málaga), Málaga, Spain.
Ian MorillaUniversidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, And IBIMA (Biomedical Research Institute of Málaga), Málaga, Spain.
Anibal BuenoUniversidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, And IBIMA (Biomedical Research Institute of Málaga), Málaga, Spain.
Beatriz Martínez-PovedaUniversidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, And IBIMA (Biomedical Research Institute of Málaga), Málaga, Spain.
Miguel Ángel MedinaUniversidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, And IBIMA (Biomedical Research Institute of Málaga), Málaga, Spain.
Juan A G RaneaUniversidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, And IBIMA (Biomedical Research Institute of Málaga), Málaga, Spain.
Instituto de Investigación Biomédica de Málaga · ESUniversidad de Málaga · ESInstituto de Investigación de Enfermedades Raras · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biocomputational network approaches are being successfully applied to predict and extract previously unknown information of novel molecular components of biological systems. In the present work, we have used this approach to predict new potential targets of anti-angiogenic therapies. For experimental validation of predictions, we made use of two

Indexed as

angiogenesismatrigel assaypredictive networkssuperoxide dismutase 3wound scratch assay

Identifiers

PMID29707113
PMCPMC5915121
OpenAlexW2795440906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.